Table 3.
Multiple regression analysis testing the independency of the association of the trough factor XIIIa level with cardiac MRI outcome variables
| Outcome | Variable | B | Standard error | T | P‐value |
|---|---|---|---|---|---|
| LVEF (Scan 1) | CK‐MB maximal | −0.019 | 0.006 | −3.084 | 0.003 |
| Pain‐to‐balloon time | 0.001 | 0.002 | 0.556 | 0.580 | |
| FXIIIa Day 2 | 0.077 | 0.046 | 1.689 | 0.095 | |
| LVEF (Scan 3) | CK‐MB maximal | −0.033 | 0.009 | −3.522 | 0.001 |
| Pain‐to‐balloon time | 0.001 | 0.002 | 0.605 | 0.547 | |
| FXIIIa Day 2 | 0.061 | 0.049 | 1.251 | 0.216 | |
| Infarct size (Scan 1) | CK‐MB maximal | 0.000 | 0.000 | 3.957 | <0.001 |
| Pain‐to‐balloon time | 0.000 | 0.000 | −0.158 | 0.875 | |
| FXIIIa Day 2 | −0.001 | 0.001 | −1.770 | 0.082 | |
| Infarct size (Scan 3) | CK‐MB maximal | 0.000 | 0.000 | 1.165 | 0.249 |
| Pain‐to‐balloon time | 0.000 | 0.000 | −0.551 | 0.584 | |
| FXIIIa Day 2 | −0.001 | 0.000 | −2.103 | 0.040 |
T indicates comparative importance of a variable in the model.
cMRI, cardiac magnetic resonance imaging; LVEF, left ventricular ejection fraction; FXIIIa, factor XIII activity; CK‐MB, creatine kinase MB isoenzyme.